489 related articles for article (PubMed ID: 24319154)
1. Iron and hepcidin: a story of recycling and balance.
Camaschella C
Hematology Am Soc Hematol Educ Program; 2013; 2013():1-8. PubMed ID: 24319154
[TBL] [Abstract][Full Text] [Related]
2. An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(-/-) mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia.
Schmidt PJ; Toudjarska I; Sendamarai AK; Racie T; Milstein S; Bettencourt BR; Hettinger J; Bumcrot D; Fleming MD
Blood; 2013 Feb; 121(7):1200-8. PubMed ID: 23223430
[TBL] [Abstract][Full Text] [Related]
3. The molecular basis of iron overload disorders and iron-linked anemias.
Kaplan J; Ward DM; De Domenico I
Int J Hematol; 2011 Jan; 93(1):14-20. PubMed ID: 21210258
[TBL] [Abstract][Full Text] [Related]
4. Systemic iron homeostasis and erythropoiesis.
Papanikolaou G; Pantopoulos K
IUBMB Life; 2017 Jun; 69(6):399-413. PubMed ID: 28387022
[TBL] [Abstract][Full Text] [Related]
5. Iron metabolism and iron disorders revisited in the hepcidin era.
Camaschella C; Nai A; Silvestri L
Haematologica; 2020; 105(2):260-272. PubMed ID: 31949017
[TBL] [Abstract][Full Text] [Related]
6. Bmp6 expression in murine liver non parenchymal cells: a mechanism to control their high iron exporter activity and protect hepatocytes from iron overload?
Rausa M; Pagani A; Nai A; Campanella A; Gilberti ME; Apostoli P; Camaschella C; Silvestri L
PLoS One; 2015; 10(4):e0122696. PubMed ID: 25860887
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the Iron Homeostatic Hormone Hepcidin.
Sangkhae V; Nemeth E
Adv Nutr; 2017 Jan; 8(1):126-136. PubMed ID: 28096133
[TBL] [Abstract][Full Text] [Related]
8. Iron Homeostasis in Health and Disease.
Gozzelino R; Arosio P
Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26805813
[TBL] [Abstract][Full Text] [Related]
9. Hepcidin and iron homeostasis.
Ganz T; Nemeth E
Biochim Biophys Acta; 2012 Sep; 1823(9):1434-43. PubMed ID: 22306005
[TBL] [Abstract][Full Text] [Related]
10. Hepcidin-ferroportin axis in health and disease.
Ginzburg YZ
Vitam Horm; 2019; 110():17-45. PubMed ID: 30798811
[TBL] [Abstract][Full Text] [Related]
11. Deletion of TMPRSS6 attenuates the phenotype in a mouse model of β-thalassemia.
Nai A; Pagani A; Mandelli G; Lidonnici MR; Silvestri L; Ferrari G; Camaschella C
Blood; 2012 May; 119(21):5021-9. PubMed ID: 22490684
[TBL] [Abstract][Full Text] [Related]
12. Regulation of hepcidin and iron-overload disease.
Lee PL; Beutler E
Annu Rev Pathol; 2009; 4():489-515. PubMed ID: 19400694
[TBL] [Abstract][Full Text] [Related]
13. A competitive enzyme-linked immunosorbent assay specific for murine hepcidin-1: correlation with hepatic mRNA expression in established and novel models of dysregulated iron homeostasis.
Gutschow P; Schmidt PJ; Han H; Ostland V; Bartnikas TB; Pettiglio MA; Herrera C; Butler JS; Nemeth E; Ganz T; Fleming MD; Westerman M
Haematologica; 2015 Feb; 100(2):167-77. PubMed ID: 25425686
[TBL] [Abstract][Full Text] [Related]
14. Hepcidin: Homeostasis and Diseases Related to Iron Metabolism.
Reichert CO; da Cunha J; Levy D; Maselli LMF; Bydlowski SP; Spada C
Acta Haematol; 2017; 137(4):220-236. PubMed ID: 28514781
[TBL] [Abstract][Full Text] [Related]
15. Hepcidin.
Ganz T
Rinsho Ketsueki; 2016; 57(10):1913-1917. PubMed ID: 27725588
[TBL] [Abstract][Full Text] [Related]
16. Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis.
Nemeth E; Ganz T
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204327
[TBL] [Abstract][Full Text] [Related]
17. Physiological and pathophysiological mechanisms of hepcidin regulation: clinical implications for iron disorders.
Xu Y; Alfaro-Magallanes VM; Babitt JL
Br J Haematol; 2021 Jun; 193(5):882-893. PubMed ID: 33316086
[TBL] [Abstract][Full Text] [Related]
18. The erythroid function of transferrin receptor 2 revealed by Tmprss6 inactivation in different models of transferrin receptor 2 knockout mice.
Nai A; Pellegrino RM; Rausa M; Pagani A; Boero M; Silvestri L; Saglio G; Roetto A; Camaschella C
Haematologica; 2014 Jun; 99(6):1016-21. PubMed ID: 24658816
[TBL] [Abstract][Full Text] [Related]
19. TMPRSS6 as a Therapeutic Target for Disorders of Erythropoiesis and Iron Homeostasis.
Ganz T; Nemeth E; Rivella S; Goldberg P; Dibble AR; McCaleb ML; Guo S; Monia BP; Barrett TD
Adv Ther; 2023 Apr; 40(4):1317-1333. PubMed ID: 36690839
[TBL] [Abstract][Full Text] [Related]
20. SLN124, a GalNac-siRNA targeting transmembrane serine protease 6, in combination with deferiprone therapy reduces ineffective erythropoiesis and hepatic iron-overload in a mouse model of β-thalassaemia.
Vadolas J; Ng GZ; Kysenius K; Crouch PJ; Dames S; Eisermann M; Nualkaew T; Vilcassim S; Schaeper U; Grigoriadis G
Br J Haematol; 2021 Jul; 194(1):200-210. PubMed ID: 33942901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
